Oxa-noribogaine

Oxa-noribogaine
Clinical data
Other namesOxanoribogaine; Oxa-noriboga; 16-Oxanoribogaine; Furanyl-noribogaine; 12-Hydroxy-16-oxaibogamine; 16-Oxaibogamin-12-ol
Drug classκ-Opioid receptor agonist
Identifiers
  • (1R,15S,17S)-17-ethyl-3-oxa-13-azapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol
PubChem CID
Chemical and physical data
FormulaC19H23NO2
Molar mass297.398 g·mol−1
3D model (JSmol)
  • CC[C@H]1C[C@H]2C[C@@H]3C1N(C2)CCC4=C3OC5=C4C=C(C=C5)O
  • InChI=1S/C19H23NO2/c1-2-12-7-11-8-16-18(12)20(10-11)6-5-14-15-9-13(21)3-4-17(15)22-19(14)16/h3-4,9,11-12,16,18,21H,2,5-8,10H2,1H3/t11-,12-,16+,18?/m0/s1
  • Key:FZMCHQSKCBWMJA-UPHWXITMSA-N

Oxa-noribogaine is an atypical κ-opioid receptor agonist of the "oxa-iboga" family and a synthetic benzofuran analogue of noribogaine. Although it still binds to hERG with similar avidity as noribogaine, it appears to be devoid of the proarrhythmic side effects of noribogaine.